1290 Avantis U.S. Large Cap Growth A TNRAX Fund Analysis

| Medalist Rating as of | See 1290 Funds Investment Hub

Morningstar’s Analysis TNRAX

Will TNRAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in 1290 Avantis U.S. Large Cap Growth A's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center